• Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)

  • Sep 25 2024
  • Length: 27 mins
  • Podcast

Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)

Listen for free

View show details

  • Summary

  • Featuring a slide presentation and related discussion from Dr Tiffany A Traina, including the following topics:

    • Extended follow-up with pembrolizumab/chemotherapy for patients with previously untreated PD-L1-positive metastatic triple-negative breast cancer (mTNBC) (0:00)
    • ASCENT trial: Survival advantage with sacituzumab govitecan versus physician’s choice of chemotherapy for patients with relapsed/refractory TNBC (2:49)
    • Treatment-associated side effects with sacituzumab govitecan (5:32)
    • Activity of sacituzumab govitecan irrespective of TROP2 expression level and in patients with brain metastases (6:48)
    • Ongoing Phase III studies evaluating sacituzumab govitecan in earlier lines of treatment (eg, ASCENT-03, ASCENT-04) (8:51)
    • Efficacy and tolerability of trastuzumab deruxtecan in patients with HER2-low and HER2-ultralow metastatic breast cancer (10:26)
    • Activity and ongoing investigations of other novel agents and strategies for mTNBC (20:05)

    CME information and select publications
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available